Brazil's health ministry said Monday it would not change its recommendation to treat coronavirus with hydroxychloroquine, despite the World Health Organization deciding to suspend trials of the drug over safety concerns.
May 26, 2020
1
4
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National ...
May 14, 2020
0
4
A study of electronic medical records from US Veterans Health Administration medical centers has found that hydroxychloroquine—with or without azithromycin—did not reduce the risk of ventilation or death and was associated ...
Jun 5, 2020
0
14
James O'Dell, M.D., chief of the Veterans Administration Nebraska-Western Iowa Health Care System's Omaha medical center and the UNMC divisions of rheumatology and immunology, is the primary author of a study that has been ...
Jun 13, 2013
0
0
(HealthDay)—For hospitalized patients with COVID-19, the addition of zinc sulfate to hydroxychloroquine and azithromycin may improve some outcomes, according to a study not yet peer reviewed and posted on medRxiv.org.
May 13, 2020
0
2
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased ...
Aug 27, 2020
0
10
Swiss pharmaceutical giant Novartis said Monday it would sponsor a clinical trial in the US using hydroxychloroquine to treat patients hospitalised with COVID-19.
Apr 20, 2020
0
3
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response (a 20 percent ...
May 25, 2011
0
0
People with rheumatoid arthritis are at increased risk of cardiovascular (CV) disease, with studies indicating an approximate 50 percent increase in risk of CV events such as heart attack and stroke. Some immunomodulators—drugs ...
Dec 5, 2022
0
7
(HealthDay)—The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University ...
Apr 8, 2020
0
3
